ENANTA Study

NOW ENROLLING: A NEW STUDY OF A 5 DAY DOSE OF INVESTIGATIONAL ORAL MEDICATION FOR THE TREATMENT OF COLD AND FLU -LIKE SYMPTOMS CAUSED BY RESPIRATORY SYNCYTIAL VIRUS (RSV)

Lakeland Clinical Trials is conducting a clinical trial to investigate a new medication for RSV

You may be eligible to participate if:

  • Have experienced up to 48 hours of cold/flu-like symptoms with at least one of the following: Nasal discharge, nasal congestion, malaise/tiredness, headache, sinus congestion, sneezing, sore throat, hoarseness, cough, shortness of breath, respiratory wheeze, earache, and/or symptoms of fever.
  • You are aged 18-75 years old
  • Are not in need of hospitalisation or emergency care.

The study will compare the active study drug to placebo (a 'dummy' medication).

One person in two will receive the placebo and one people in two will receive active study drug. This will be decided randomly and participants will not know which of these they receive during the study.

This trial is currently enrolling. If you are interested please apply via the 'APPLY TO PARTICIPATE' button.

Project Data

SPONSOR

ENANTA Pharmaceuticals 

Apply to Participate

Related Clinical TrialsCheck out all our related clinical trials

PROTECTOR Study

Respiratory Tract Infection